• Return to Headlines

Relatively High Return on Equity Detected in Shares of Abbvie Inc in the Biotechnology Industry (ABBV, CNCE, EXEL, CELG, CCXI)

By James Quinn

Below are the three companies in the Biotechnology industry with the highest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and are growing.

Abbvie Inc ranks highest with a ROE of 14,856.7%. Concert Pharmace is next with a ROE of 7,272.9%. Exelixis Inc ranks third highest with a ROE of 6,418.7%.

Celgene Corp follows with a ROE of 4,391.4%, and Chemocentryx Inc rounds out the top five with a ROE of 4,018.7%.

SmarTrend recommended that its subscribers protect gains by selling shares of Chemocentryx Inc on April 15th, 2019 by issuing a Downtrend alert when the shares were trading at $12.97. Since that call, shares of Chemocentryx Inc have fallen 33.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: highest return on equity abbvie inc concert pharmace exelixis inc celgene corp chemocentryx inc